Discover how CRISPR-Cas9 technology is revolutionizing lung cancer research by identifying genetic vulnerabilities in EGFR-mutant non-small cell lung cancer cells.
Discover how FBXL16 protein stabilizes IRS1 signaling in KRAS-mutant lung adenocarcinomas, revealing new therapeutic targets for this challenging cancer.
Exploring how targeting DCN1-mediated neddylation offers new hope for lung squamous cell carcinoma treatment through innovative small-molecule inhibitors.
Discover how Vialinin A, a compound from edible mushrooms, shows promise in preventing lung cancer growth through antioxidant properties and unique molecular mechanisms.
Discover how tyrosine phosphorylation of β-catenin drives drug resistance in EGFR-mutant lung cancer and the promising research behind this molecular mechanism.
Discover how SHetA2 overcomes lung cancer resistance by down-regulating c-FLIP and survivin to enhance TRAIL-induced apoptosis.